Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dual specificity protein phosphatase 13A (DUSP13A) is an enzyme of the protein tyrosine phosphatase superfamily that acts on both phosphotyrosine and phosphoserine/threonine residues. It is expressed primarily in skeletal muscle and has regulatory roles in apoptosis signaling (notably MAP3K5/ASK1-mediated pathways). DUSP13A is considered a druggable target due to its allosteric sites as revealed by structural studies, with potential roles in cell growth, differentiation, and disease states including certain cancers and metabolic disorders
Drugs targeting DUSP13A would likely act as allosteric modulators or inhibitors of phosphatase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dual specificity protein phosphatase 13A (DUSP13A).